Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B

International Journal of Infectious Diseases

Volumn 16, Issue 3, 2012, Pages

  Chen, YongFa ^a   Ju, Ting ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Adefovir dipivoxil; Chronic hepatitis B; Lamivudine; Lamivudine resistant; Meta analysis

Indexed keywords

ADEFOVIR DIPIVOXIL; ALANINE AMINOTRANSFERASE; LAMIVUDINE; VIRUS DNA;

ANTIVIRAL THERAPY; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; META ANALYSIS; MONOTHERAPY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS DETECTION; VIRUS RESISTANCE;

ADENINE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; PHOSPHONIC ACIDS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84857065301     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2011.11.006     Document Type: Review

References (20)

1. Lok A.S., McMahon B.J. Chronic hepatitis B. Hepatology 2007, 45:507-539.
2. Lee W.M. Hepatitis B virus infection. N Engl J Med 1997, 337:1733-1745.
3. Maddrey W.C. Hepatitis B: an important public health issue. J Med Virol 2000, 61:362-366.
4. Si C.W. The progress of antivirus therapy of chronic hepatitis B. Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases 2003, 13:45-47.
5. Li C., Wan M.B. Comparison and interpretation of chronic hepatitis B guidelines on the antivirus treatment. Chinese Journal of Practical Internal Medicine 2010, 30:1085-1087.
6. Mutimer D. Review article: hepatitis B and liver transplantation. Aliment Pharmacol Ther 2006, 23:1031-1041.
7. Liaw Y.F. The current management of HBV drug resistance. J Clin Virol 2005, 34:S143-S146.
8. Zhang L., Wu H.H. The progress of the treatment of chronic hepatitis B patients with nucleos(t)ide analogs resistance. Clinical Medicine 2011, 31:104-105.
9. Dong R.L., Li F. The progress of antiviral resistance in treating with nucleos(t)ide analogs for hepatitis B. Medical Recapitulate 2010, 16:2590-2593.
10. Yang P.Y., Liu S.H., Feng B. Effect of adefovir and lamivudine combination therapy on lamivudine resistance patients. Journal of the Fourth Military Medical University 2008, 29:155-157.
11. Luo P.D. An observation on the efficacy of adefovir dipivoxil combined with lamivudine for chronic hepatitis B patients with YMDD mutation. Shandong Medical Journal 2009, 49:65-66.
12. Zhan G.Q., Zhu L., Li J.K., Xie X.R., Li G. An observation on the efficacy of adefovir dipivoxil combined with lamivudine for chronic hepatitis B patients with lamivudine-resistant. Chinese Journal of Clinical Hepatology 2009, 25:274-276.
13. Gaia S., Barbon V., Smedile A., Olivero A., Carenzi S., Lagget M., et al. Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine. J Hepatol 2008, 48:540-547.
14. - chronic hepatitis B patients: a 4-year study. J Gastroenterol Hepatol 2009, 25:54-60.
15. Rapti I., Dimou E., Mitsoula P., Hadziyannis S.J. Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B. Hepatology 2007, 45:307-313.
16. Peters M.G., Hann H.W., Martin P., Heathcote E.J., Buggisch P., Rubin R., et al. Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B. Gastroenterology 2004, 126:91-101.
17. Fung J., Lai C.L., Yuen J.C., Wong D.K., Tanaka Y., Mizokami M., et al. Adefovir dipivoxil monotherapy and combination therapy with lamivudine for the treatment of chronic hepatitis B in an Asian population. Antivir Ther 2007, 12:41-46.
18. Santantonio T., Fasano M., Durantel S., Barraud L., Heichen M., Guastadisegni A., et al. Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B. Antivir Ther 2009, 14:557-565.
19. Kim K.M., Choi W.B., Lim Y.S., Lee H.C., Chung Y.H., Lee Y.S., et al. Adefovir dipivoxil alone or in combination with ongoing lamivudine in patients with decompensated liver disease and lamivudine-resistant hepatitis B virus. J Korean Med Sci 2005, 20:821-828.
20. Manolakopoulos S., Bethanis S., Koutsounas S., Goulis J., Vlachogiannakos J., Christias E., et al. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine. Aliment Pharmacol Ther 2008, 27:266-273.